Search Results 1471-1480 of 40327 for Two-phase

  1. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Malaria - Symptoms & causes - Mayo Clinic

    If you live in or are traveling to an area where malaria is common, take steps to avoid mosquito bites. ... 2-undecanone. Do not use a spray directly on ...

  3. Chemotherapy and hair loss: What to expect during treatment - Mayo Clinic

    Hair usually begins falling out 2 to 4 weeks after you start treatment. It ... Metastatic (stage 4) prostate cancer · Metastatic castration-resistant ...

  4. Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Hepatitis B - Symptoms and causes - Mayo Clinic

    The vaccine is given as two shots one month apart, or three or four shots over six months. ... People with end-stage kidney disease. Travelers ... MELD (model for ...

  6. Publications - Roberto A. Leon-Ferre, M.D. - Mayo Clinic

    ... Phase 2 TBCRC041 Randomized Clinical Trial. JAMA Oncol. 2023 Jun 1; 9 (6):815-824. View PubMed; Leon-Ferre RA, Goetz MP. Advances in systemic therapies for ...

  7. ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

    There will be two arms in this study, a ... Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  10. Study of Brentuximab Vedotin Combined With RCHOP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...